… of Parkinson’s disease at very different ages, from early thirties to late eighties. In this proposal, we … 76 or older. The variants common to one group of patients (early or late onset) and lacking in the other will be the … G2019S carriers from the same population. Relevance to Diagnosis/Treatment of Parkinson’s Disease:   The …

… in PD and disease-related changes in the brain. Impact on Diagnosis/Treatment of Parkinson's disease: We aim to define CD163 as an easily accessible biomarker useful in diagnosis and tracking of disease progression. In addition, … Research Grant …

… of a statewide disease registry would facilitate research into PD etiology, The California Parkinson’s Disease … and create a database of persons with this disease for research purposes. … MJFF Research Grant …

… This grant builds upon the research from a prior grant: Dry Powder-Based Delivery of … disease. The unique pharmacokinetic profile translates into rapid and durable improvement in motor function without … (for example, carbidopa) oral regimen. Importance of This Research for the Development of a New PD Therapy        This …

… tissue over the course of Parkinson’s disease. Relevance to Diagnosis/Treatment of Parkinson’s Disease: Understanding … of the LRRK2 protein has the potential to provide insight into the causes of Parkinson’s disease. Furthermore, LRRK2 … Research Grant …

… (AAV) are the current choice to deliver therapeutic genes into the brain due to their safety profile, as demonstrated … proteome (protein network) under chronic damage. Impact on Diagnosis/Treatment of Parkinson's Disease: We plan to … known as the UPR, in the development of PD. This research aims to determine if the UPR is a valid target to …